An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity

DOI: 10.1159/000479978

Keywords: Antibody therapy, Fc engineering, ADCC, CDC, CD20

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text